{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-004095","form_type":"8-K","ticker":"BRGX","cik":"0001593184","company_name":"BIOREGENX, INC.","filed_at":"2024-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.134317+00:00","generated_at":"2026-06-01T05:03:14.370227+00:00","sec_items":["4.01","4.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"BioRegenx restates Q1 2024 financials; appoints Weinberg & Co. as new auditor","bullets":["Engaged Weinberg & Company as new independent accountant for fiscal years ended Dec 31, 2023 and 2022, effective June 10, 2024.","Concluded Q1 2024 Form 10-Q and 10-Q/A should no longer be relied upon due to lack of auditor review prior to filing.","Management evaluating restatement impact on financials and internal controls; will file amended 10-Q/A as soon as practical.","No prior consultations with Weinberg on accounting principles or disagreements during past two fiscal years and subsequent interim period."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-004095","json":"https://secwatch.observer/filing/0001683168-24-004095.json","markdown":"https://secwatch.observer/filing/0001683168-24-004095.md","text":"https://secwatch.observer/filing/0001683168-24-004095.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824004095/0001683168-24-004095-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1593184/000168316824004095/bioregenx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:03:14.370227+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}